(Lecture)Lecture at “The 58th Annual Conference of The Japanese Society of Inheraited Metabolic Diseases” (October 27, 2016)
date : 10/27/2016
Toshio Miyata, HGPI Board Member, delivered a lecture titled, “Overview of rare disease policy in Japan” .
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Publication Report] Planetary Health Promotion Project “Issues Facing Planetary Health and the Role of the Health Sector” (May 10, 2023)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] HGPI Joins Global Green and Healthy Hospitals (August 1, 2023)
Featured Posts
-
2025-11-13
[Registration Open] (Webinar) The 1st J-PEP Seminar – Initiating Policy Advocacy from Meaningful Involvement (December 8, 2025)
-
2025-12-01
[Policy Recommendations] Recommendations on Strategic Investments in Policies for Brain Health to Revitalize Japan: Hopes for the New Administration (December 1, 2025)



